Medicinal cannabis is one of the world’s fastest growing industries and is set to become one of the largest sectors of the healthcare market.
Medicinal uses of cannabis date back from over 5,000 years ago. Cannabis has evolved hand-in-hand alongside humans for millennia to be a power-source of potential – and Bod is dedicated to uncovering its therapeutic benefits.
One of the many advantages of medicinal cannabis over recreational cannabis is the stringent quality control assessments that products must undergo to be approved. Quality control ensures patients will receive a known and regulated dosing of cannabinoids, whilst also ensuring the absence of impurities, such as pathogens, heavy metals and pesticides.
Bod consistently surpasses the national quality control standards, so patients and physicians can be confident knowing they are always using or prescribing premium products.
In Australia, medicinal cannabis is a prescription-only medicine that can be prescribed by any Australian registered medical doctor. It can be used for any condition lasting longer than 3 months that hasn’t responded to conventional treatments, and where there is evidence to support its use.
Currently, medicinal cannabis has been approved for use in Australia for conditions including:
– Different types of pain (e.g. chronic pain, cancer pain and neuropathic pain)
– Neurological conditions (e.g. epilepsy, dementia, multiple sclerosis and autism)
– Psychological conditions (e.g. anxiety and depression)
– Palliative and chemotherapy-associated symptoms
Medicinal cannabis is improving the lives of many, which is clearly demonstrated by the increasing number of repeat prescriptions.
Bod are at the forefront in discovering how to utilise medicinal cannabis. Our work is expanding the clinically-based indications that medicinal cannabis improves – further driving prescription volumes.
We are working with the leading health and research facilities to conduct the high-quality research needed in this area. This is evident in Bod’s involvement in Project Twenty21, the largest ever medicinal cannabis research project, aiming to investigate the therapeutic potential of medicinal cannabis in 20,000 patients.
Further, Bod is working with the Lambert Initiative for Cannabinoid Therapeutics, at the University of Sydney, along with the University of Technology and University of South Australia to help define the next generation of cannabis medicines.
We are also educating and empowering healthcare professionals with an extensive suite of educational programs and resources on medicinal cannabis, cannabis science and the endocannabinoid system. We want to provide practitioners with the confidence and tools required to not only prescribe and administer medicinal cannabis, but also provide more comprehensive care for their patients.
To find out more about medicinal cannabis, including eligibility and how to access it, click below.